• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Burning Rock Biotech Ltd ADR (NQ: BNR )

    5.520 UNCHANGED
    Streaming Delayed Price Updated: 2:47 PM EDT, Jul 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1
    Open 5.520
    Bid (Size) 4.440 (1)
    Ask (Size) 6.200 (1)
    Prev. Close 5.520
    Today's Range 5.520 - 5.520
    52wk Range 0.5722 - 8.990
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
    Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... 
    Via Talk Markets

    Performance

    YTD
    +469.66%
    +469.66%
    1 Month
    -29.23%
    -29.23%
    3 Month
    +645.95%
    +645.95%
    6 Month
    +497.34%
    +497.34%
    1 Year
    +154.38%
    +154.38%

    More News

    Read More
    Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    BNR Stock Earnings: Burning Rock Biotech Reported Results for Q1 2024
    Via InvestorPlace
    Burning Rock Reports First Quarter 2024 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Publishes 2023 Annual Report on Form 20-F
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces ADS Ratio Change
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Three AI Stocks That Are Trading At A Discount In April 2024
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023
    Via InvestorPlace
    Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Burning Rock Announces Receipt of Notification from NASDAQ
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces Results of 2023 Annual General Meeting
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Earnings Scheduled For November 30, 2023
    Via Benzinga
    Burning Rock Reports Third Quarter 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Burning Rock Reports Second Quarter 2023 Financial Results
    From Burning Rock Biotech Limited
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.